MOUNTAIN VIEW, Calif.,
Dec. 8, 2016 /PRNewswire/ -- IRIDEX
Corporation (NASDAQ: IRIX) today announced that it intends to offer
newly issued shares of common stock, $0.01 par value (the "Offering" with such shares
being the "Shares") pursuant to an underwritten public offering.
The final terms of the Offering will depend on market and
other conditions at the time of pricing, and there can be no
assurance as to whether or when the Offering may be completed.
IRIDEX expects to use the net proceeds it will receive from this
offering for working capital and other general corporate
purposes. IRIDEX may also use a portion of the net proceeds
for licensing or acquiring intellectual property or technologies to
incorporate in its products, capital expenditures, to fund possible
investments in and acquisitions of complementary businesses,
partnerships, minority investments or to repay
indebtedness.
Roth Capital Partners is acting as sole manager for the proposed
Offering.
A shelf registration statement (File No. 333-213094) relating to
the shares of common stock to be issued in the proposed offering
was filed with the Securities and Exchange Commission (the "SEC")
and was declared effective on August 26,
2016. This press release shall not constitute an offer to
sell or the solicitation of an offer to buy any of the securities
described herein, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction. Copies of
the preliminary prospectus supplement and accompanying prospectus
will be filed with the Securities and Exchange Commission and, when
available, may be obtained from Roth Capital Partners, LLC, 888 San
Clemente, Newport Beach, CA 92660,
(800) 678-9147 or email: rothecm@roth.com, by accessing the EDGAR
database on the SEC's website at www.sec.gov, or by writing or
calling IRIDEX at 1212 Terra Bella Avenue, Mountain View, CA 94043 or (650) 940-4700.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities in this offering.
There shall not be any sale of these securities in any state
or jurisdiction in which such offering, sale or solicitation would
be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a leader in
developing, manufacturing, and marketing innovative and versatile
laser-based medical systems, delivery devices and consumable
instrumentation for the ophthalmology market.
IRIDEX products are sold in the United States through both direct and
independent sales forces and internationally through a combination
of a direct sales force and a network of approximately 70
independent distributors into over 100 countries.
Logo - http://photos.prnewswire.com/prnh/20141001/149809
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/iridex-corporation-announces-proposed-public-offering-of-common-stock-300375656.html
SOURCE IRIDEX Corporation